SAN RAFAEL, Calif., April 13, 2023 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, April 26, at 4:30 p.m. ET to discuss first-quarter 2023 financial results and provide a general…Read More
BioMarin to Host First Quarter 2023 Financial Results Conference Call and Webcast on Wednesday April 26 at 430pm ET
